Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-021376

Chief Executive Officer acquired 6,068 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meckler Jeffrey A Chief Executive Officer 2025-07-27 Grant or award +6,068 $8.30 $50,379 13,312 D
Derivatives
Meckler Jeffrey A Chief Executive Officer 2025-07-27 Grant or award · Common Stock Warrants +12,136 $8.30 $100,758 16,688 D
Loading xslF345X05/ownership.xml…